respiratory 2.1 (rp2.1) panel (BioFire Defense)
90
Structured Review
BioFire Defense
respiratory 2.1 (rp2.1) panel
Respiratory 2.1 (Rp2.1) Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/respiratory+panel+2%2E1/respiratory+panel+2+1/pm40644973-120-21-27
Average 90 stars, based on 1 article reviews
Respiratory 2.1 (Rp2.1) Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/respiratory+panel+2%2E1/respiratory+panel+2+1/pm40644973-120-21-27
Average 90 stars, based on 1 article reviews
respiratory 2.1 (rp2.1) panel - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Diagnostic Assay:Article Title: APSR Annual Conference - 28 th Congress of the Asian Pacific Society of Respirology, 7-10 November 2024, Hong Kong. Article Snippet: Article Title: Unveiling the dynamics of respiratory infections revealed by multiplex PCR testing during the COVID-19 pandemic in Taiwan, 2020-2023. Article Snippet: Annual distribution of viral pathogens detected by the Article Title: Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections. Article Snippet: Performance characteristics of commonly used multiplex respiratory molecular panels and their clinical applications were recently reviewed in a review article by Contes and Liu [74], including Article Title: Point-of-Care Multiplex Detection of Respiratory Viruses. Article Snippet: The COVID-19 pandemic, in addition to the cooccurrence of influenza virus and respiratory syncytial virus (RSV), has emphasized the requirement for efficient and reliable multiplex diagnostic methods for respiratory infections.. While existing multiplex detection techniques are based on reverse transcription quantitative polymerase chain reaction (RT-qPCR) and extraction and purification kits, the need for complex instrumentation and elevated cost limit their scalability and availability.. In this study, we have developed a point-of-care (POC) device based on reverse transcription loop-mediated isothermal amplification (RT-LAMP) that can simultaneously detect four respiratory viruses (SARSCoV-2, Influenza A, Influenza B, and RSV) and perform two controls in less than 30 min, while avoiding the use of the RNA extraction kit. Article Title: Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs. Article Snippet: Here, we determined the clinical performance of the Article Title: Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs Article Snippet: Here, we determined the clinical performance of the Article Title: Epidemiology, Clinical Significance, and Diagnosis of Respiratory Viruses and Their Co-Infections in the Post-COVID Era. Article Snippet: With the emergence of SARS-CoV-2, respiratory panels for diagnostic testing were altered to include SARS-CoV-2, one being the Article Title: Unveiling the dynamics of respiratory infections revealed by multiplex PCR testing during the COVID-19 pandemic in Taiwan, 2020-2023. Article Snippet: We also observed the prevalence (Table 3) of each age group among positive samples detected by the Multiplex Assay:Article Title: APSR Annual Conference - 28 th Congress of the Asian Pacific Society of Respirology, 7-10 November 2024, Hong Kong. Article Snippet: Article Title: Unveiling the dynamics of respiratory infections revealed by multiplex PCR testing during the COVID-19 pandemic in Taiwan, 2020-2023. Article Snippet: Annual distribution of viral pathogens detected by the Article Title: Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections. Article Snippet: Performance characteristics of commonly used multiplex respiratory molecular panels and their clinical applications were recently reviewed in a review article by Contes and Liu [74], including Article Title: Point-of-Care Multiplex Detection of Respiratory Viruses. Article Snippet: The COVID-19 pandemic, in addition to the cooccurrence of influenza virus and respiratory syncytial virus (RSV), has emphasized the requirement for efficient and reliable multiplex diagnostic methods for respiratory infections.. While existing multiplex detection techniques are based on reverse transcription quantitative polymerase chain reaction (RT-qPCR) and extraction and purification kits, the need for complex instrumentation and elevated cost limit their scalability and availability.. In this study, we have developed a point-of-care (POC) device based on reverse transcription loop-mediated isothermal amplification (RT-LAMP) that can simultaneously detect four respiratory viruses (SARSCoV-2, Influenza A, Influenza B, and RSV) and perform two controls in less than 30 min, while avoiding the use of the RNA extraction kit. Article Title: Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs. Article Snippet: Here, we determined the clinical performance of the Article Title: Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs Article Snippet: Here, we determined the clinical performance of the Article Title: Epidemiology, Clinical Significance, and Diagnosis of Respiratory Viruses and Their Co-Infections in the Post-COVID Era. Article Snippet: With the emergence of SARS-CoV-2, respiratory panels for diagnostic testing were altered to include SARS-CoV-2, one being the Article Title: Unveiling the dynamics of respiratory infections revealed by multiplex PCR testing during the COVID-19 pandemic in Taiwan, 2020-2023. Article Snippet: We also observed the prevalence (Table 3) of each age group among positive samples detected by the Polymerase Chain Reaction:Article Title: APSR Annual Conference - 28 th Congress of the Asian Pacific Society of Respirology, 7-10 November 2024, Hong Kong. Article Snippet: Article Title: Unveiling the dynamics of respiratory infections revealed by multiplex PCR testing during the COVID-19 pandemic in Taiwan, 2020-2023. Article Snippet: Annual distribution of viral pathogens detected by the Article Title: Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections. Article Snippet: Performance characteristics of commonly used multiplex respiratory molecular panels and their clinical applications were recently reviewed in a review article by Contes and Liu [74], including Article Title: Point-of-Care Multiplex Detection of Respiratory Viruses. Article Snippet: The COVID-19 pandemic, in addition to the cooccurrence of influenza virus and respiratory syncytial virus (RSV), has emphasized the requirement for efficient and reliable multiplex diagnostic methods for respiratory infections.. While existing multiplex detection techniques are based on reverse transcription quantitative polymerase chain reaction (RT-qPCR) and extraction and purification kits, the need for complex instrumentation and elevated cost limit their scalability and availability.. In this study, we have developed a point-of-care (POC) device based on reverse transcription loop-mediated isothermal amplification (RT-LAMP) that can simultaneously detect four respiratory viruses (SARSCoV-2, Influenza A, Influenza B, and RSV) and perform two controls in less than 30 min, while avoiding the use of the RNA extraction kit. Article Title: Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs. Article Snippet: Here, we determined the clinical performance of the Article Title: Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs Article Snippet: Here, we determined the clinical performance of the Article Title: Epidemiology, Clinical Significance, and Diagnosis of Respiratory Viruses and Their Co-Infections in the Post-COVID Era. Article Snippet: With the emergence of SARS-CoV-2, respiratory panels for diagnostic testing were altered to include SARS-CoV-2, one being the Article Title: Unveiling the dynamics of respiratory infections revealed by multiplex PCR testing during the COVID-19 pandemic in Taiwan, 2020-2023. Article Snippet: We also observed the prevalence (Table 3) of each age group among positive samples detected by the Virus:Article Title: APSR Annual Conference - 28 th Congress of the Asian Pacific Society of Respirology, 7-10 November 2024, Hong Kong. Article Snippet: Article Title: Unveiling the dynamics of respiratory infections revealed by multiplex PCR testing during the COVID-19 pandemic in Taiwan, 2020-2023. Article Snippet: Annual distribution of viral pathogens detected by the Article Title: Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections. Article Snippet: Performance characteristics of commonly used multiplex respiratory molecular panels and their clinical applications were recently reviewed in a review article by Contes and Liu [74], including Article Title: Point-of-Care Multiplex Detection of Respiratory Viruses. Article Snippet: The COVID-19 pandemic, in addition to the cooccurrence of influenza virus and respiratory syncytial virus (RSV), has emphasized the requirement for efficient and reliable multiplex diagnostic methods for respiratory infections.. While existing multiplex detection techniques are based on reverse transcription quantitative polymerase chain reaction (RT-qPCR) and extraction and purification kits, the need for complex instrumentation and elevated cost limit their scalability and availability.. In this study, we have developed a point-of-care (POC) device based on reverse transcription loop-mediated isothermal amplification (RT-LAMP) that can simultaneously detect four respiratory viruses (SARSCoV-2, Influenza A, Influenza B, and RSV) and perform two controls in less than 30 min, while avoiding the use of the RNA extraction kit. Article Title: Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs. Article Snippet: Here, we determined the clinical performance of the Article Title: Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs Article Snippet: Here, we determined the clinical performance of the Article Title: Epidemiology, Clinical Significance, and Diagnosis of Respiratory Viruses and Their Co-Infections in the Post-COVID Era. Article Snippet: With the emergence of SARS-CoV-2, respiratory panels for diagnostic testing were altered to include SARS-CoV-2, one being the Article Title: Unveiling the dynamics of respiratory infections revealed by multiplex PCR testing during the COVID-19 pandemic in Taiwan, 2020-2023. Article Snippet: We also observed the prevalence (Table 3) of each age group among positive samples detected by the Bacteria:Article Title: APSR Annual Conference - 28 th Congress of the Asian Pacific Society of Respirology, 7-10 November 2024, Hong Kong. Article Snippet: Article Title: Unveiling the dynamics of respiratory infections revealed by multiplex PCR testing during the COVID-19 pandemic in Taiwan, 2020-2023. Article Snippet: Annual distribution of viral pathogens detected by the Article Title: Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections. Article Snippet: Performance characteristics of commonly used multiplex respiratory molecular panels and their clinical applications were recently reviewed in a review article by Contes and Liu [74], including Article Title: Point-of-Care Multiplex Detection of Respiratory Viruses. Article Snippet: The COVID-19 pandemic, in addition to the cooccurrence of influenza virus and respiratory syncytial virus (RSV), has emphasized the requirement for efficient and reliable multiplex diagnostic methods for respiratory infections.. While existing multiplex detection techniques are based on reverse transcription quantitative polymerase chain reaction (RT-qPCR) and extraction and purification kits, the need for complex instrumentation and elevated cost limit their scalability and availability.. In this study, we have developed a point-of-care (POC) device based on reverse transcription loop-mediated isothermal amplification (RT-LAMP) that can simultaneously detect four respiratory viruses (SARSCoV-2, Influenza A, Influenza B, and RSV) and perform two controls in less than 30 min, while avoiding the use of the RNA extraction kit. Article Title: Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs. Article Snippet: Here, we determined the clinical performance of the Article Title: Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs Article Snippet: Here, we determined the clinical performance of the Article Title: Epidemiology, Clinical Significance, and Diagnosis of Respiratory Viruses and Their Co-Infections in the Post-COVID Era. Article Snippet: With the emergence of SARS-CoV-2, respiratory panels for diagnostic testing were altered to include SARS-CoV-2, one being the Article Title: Unveiling the dynamics of respiratory infections revealed by multiplex PCR testing during the COVID-19 pandemic in Taiwan, 2020-2023. Article Snippet: We also observed the prevalence (Table 3) of each age group among positive samples detected by the |